Bupropion

This classification denotes an antidepressant agent with the molecular formula C13H18ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 01ZG3TPX31, chemically known as 1-propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)- but generally known as bupropion, which bears US NIH Compound Identifier 444. Bupropion most often comes in base and hydrochloride forms. European Medicines Agency schedules Bupropion in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05413MIG. The term BUPROPION is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 No. 1, 2001, List 45). World Health Organization schedules bupropion in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, BUPROPION remains the US FDA Preferred Term for this commodity. Bupropion bears US NLM identifiers UMLS ID C0085208 and NCI Concept Code C62012. SMILES: Clc1cc(C(=O)C(NC(C)(C)C)C)ccc1.